307 related articles for article (PubMed ID: 14741152)
1. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.
Ivory CP; Chadee K
Infect Immun; 2007 Oct; 75(10):4917-22. PubMed ID: 17620349
[TBL] [Abstract][Full Text] [Related]
3. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine.
Barroso L; Abhyankar M; Noor Z; Read K; Pedersen K; White R; Fox C; Petri WA; Lyerly D
Vaccine; 2014 Feb; 32(10):1218-24. PubMed ID: 23827311
[TBL] [Abstract][Full Text] [Related]
7. Entamoeba histolytica: from adherence to enteropathy.
Ravdin JI
J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786
[TBL] [Abstract][Full Text] [Related]
8. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica.
Mann BJ; Burkholder BV; Lockhart LA
Vaccine; 1997; 15(6-7):659-63. PubMed ID: 9178467
[TBL] [Abstract][Full Text] [Related]
9. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the PE
Martínez-Hernández SL; Becerra-González VM; Muñoz-Ortega MH; Loera-Muro VM; Ávila-Blanco ME; Medina-Rosales MN; Ventura-Juárez J
J Immunol Res; 2021; 2021():6697900. PubMed ID: 33824880
[No Abstract] [Full Text] [Related]
11. Identification of the galactose-adherence lectin epitopes of Entamoeba histolytica that stimulate tumor necrosis factor-alpha production by macrophages.
Séguin R; Mann BJ; Keller K; Chadee K
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12175-9. PubMed ID: 8618866
[TBL] [Abstract][Full Text] [Related]
12. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children.
Haque R; Ali IM; Sack RB; Farr BM; Ramakrishnan G; Petri WA
J Infect Dis; 2001 Jun; 183(12):1787-93. PubMed ID: 11372032
[TBL] [Abstract][Full Text] [Related]
13. VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.
Tachibana H; Watanabe K; Cheng XJ; Tsukamoto H; Kaneda Y; Takeuchi T; Ihara S; Petri WA
Infect Immun; 2003 Aug; 71(8):4313-9. PubMed ID: 12874307
[TBL] [Abstract][Full Text] [Related]
14. Vaccine prospects for amebiasis.
Chaudhry OA; Petri WA
Expert Rev Vaccines; 2005 Oct; 4(5):657-68. PubMed ID: 16221067
[TBL] [Abstract][Full Text] [Related]
15. Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity.
Kelsall BL; Ravdin JI
Infect Immun; 1995 Feb; 63(2):686-9. PubMed ID: 7822040
[TBL] [Abstract][Full Text] [Related]
16. Entamoeba histolytica: Overexpression of the gal/galnac lectin, ehcp2 and ehcp5 genes in an in vivo model of amebiasis.
Sánchez V; Serrano-Luna J; Ramírez-Moreno E; Tsutsumi V; Shibayama M
Parasitol Int; 2016 Dec; 65(6 Pt A):665-667. PubMed ID: 27616150
[TBL] [Abstract][Full Text] [Related]
17. Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo.
Ivory CP; Chadee K
Eur J Immunol; 2007 Feb; 37(2):385-94. PubMed ID: 17219364
[TBL] [Abstract][Full Text] [Related]
18. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis.
Lotter H; Zhang T; Seydel KB; Stanley SL; Tannich E
J Exp Med; 1997 May; 185(10):1793-801. PubMed ID: 9151705
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis.
Chebolu S; Daniell H
Plant Biotechnol J; 2007 Mar; 5(2):230-9. PubMed ID: 17309678
[TBL] [Abstract][Full Text] [Related]
20. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin.
Dodson JM; Lenkowski PW; Eubanks AC; Jackson TF; Napodano J; Lyerly DM; Lockhart LA; Mann BJ; Petri WA
J Infect Dis; 1999 Feb; 179(2):460-6. PubMed ID: 9878032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
